Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Site-Specific 64Cu Labeling of the Serine Protease, Active Site Inhibited Factor Seven Azide (FVIIai-N3), Using Copper Free Click Chemistry.

Jeppesen TE, Kristensen LK, Nielsen CH, Petersen LC, Kristensen JB, Behrens C, Madsen J, Kjaer A.

Bioconjug Chem. 2018 Jan 17;29(1):117-125. doi: 10.1021/acs.bioconjchem.7b00649. Epub 2017 Dec 21.

PMID:
29206443
2.

PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.

Nielsen CH, Jeppesen TE, Kristensen LK, Jensen MM, El Ali HH, Madsen J, Wiinberg B, Petersen LC, Kjaer A.

J Nucl Med. 2016 Jul;57(7):1112-9. doi: 10.2967/jnumed.115.170266. Epub 2016 Mar 24.

3.

Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.

Nielsen CH, Erlandsson M, Jeppesen TE, Jensen MM, Kristensen LK, Madsen J, Petersen LC, Kjaer A.

J Nucl Med. 2016 Jan;57(1):89-95. doi: 10.2967/jnumed.115.154849. Epub 2015 Sep 17.

4.

Facile method to radiolabel glycol chitosan nanoparticles with (64)Cu via copper-free click chemistry for MicroPET imaging.

Lee DE, Na JH, Lee S, Kang CM, Kim HN, Han SJ, Kim H, Choe YS, Jung KH, Lee KC, Choi K, Kwon IC, Jeong SY, Lee KH, Kim K.

Mol Pharm. 2013 Jun 3;10(6):2190-8. doi: 10.1021/mp300601r. Epub 2013 May 6.

PMID:
23586421
5.

A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform.

Baranyai Z, Reich D, Vágner A, Weineisen M, Tóth I, Wester HJ, Notni J.

Dalton Trans. 2015 Jun 28;44(24):11137-46. doi: 10.1039/c5dt00576k. Epub 2015 May 22.

PMID:
25999035
6.

ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment.

Luo H, England CG, Goel S, Graves SA, Ai F, Liu B, Theuer CP, Wong HC, Nickles RJ, Cai W.

Mol Pharm. 2017 May 1;14(5):1646-1655. doi: 10.1021/acs.molpharmaceut.6b01123. Epub 2017 Mar 24.

7.

Oxime Coupling of Active Site Inhibited Factor Seven with a Nonvolatile, Water-Soluble Fluorine-18 Labeled Aldehyde.

Jeppesen TE, Kristensen LK, Nielsen CH, Petersen LC, Kristensen JB, Behrens C, Madsen J, Kjaer A.

Bioconjug Chem. 2019 Mar 20;30(3):775-784. doi: 10.1021/acs.bioconjchem.8b00900. Epub 2019 Feb 6.

PMID:
30676028
8.

Immuno-PET of tissue factor in pancreatic cancer.

Hong H, Zhang Y, Nayak TR, Engle JW, Wong HC, Liu B, Barnhart TE, Cai W.

J Nucl Med. 2012 Nov;53(11):1748-54. doi: 10.2967/jnumed.112.105460. Epub 2012 Sep 17.

9.

MicroPET imaging of CD13 expression using a (64)Cu-labeled dimeric NGR peptide based on sarcophagine cage.

Li G, Wang X, Zong S, Wang J, Conti PS, Chen K.

Mol Pharm. 2014 Nov 3;11(11):3938-46. doi: 10.1021/mp500354x. Epub 2014 Jul 30.

PMID:
25054774
10.

Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry.

Baumhover NJ, Martin ME, Parameswarappa SG, Kloepping KC, O'Dorisio MS, Pigge FC, Schultz MK.

Bioorg Med Chem Lett. 2011 Oct 1;21(19):5757-61. doi: 10.1016/j.bmcl.2011.08.017. Epub 2011 Aug 8.

11.

Evaluation of an integrin αvβ6-specific peptide labeled with [18F]fluorine by copper-free, strain-promoted click chemistry.

Hausner SH, Carpenter RD, Bauer N, Sutcliffe JL.

Nucl Med Biol. 2013 Feb;40(2):233-9. doi: 10.1016/j.nucmedbio.2012.10.007. Epub 2012 Dec 21.

PMID:
23265667
12.

MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.

Boyle AJ, Cao PJ, Hedley DW, Sidhu SS, Winnik MA, Reilly RM.

Nucl Med Biol. 2015 Feb;42(2):71-7. doi: 10.1016/j.nucmedbio.2014.10.009. Epub 2014 Oct 22.

PMID:
25456837
13.

Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.

Cook BE, Adumeau P, Membreno R, Carnazza KE, Brand C, Reiner T, Agnew BJ, Lewis JS, Zeglis BM.

Bioconjug Chem. 2016 Aug 17;27(8):1789-95. doi: 10.1021/acs.bioconjchem.6b00235. Epub 2016 Jul 14.

14.

In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.

Kumar SR, Gallazzi FA, Ferdani R, Anderson CJ, Quinn TP, Deutscher SL.

Cancer Biother Radiopharm. 2010 Dec;25(6):693-703. doi: 10.1089/cbr.2010.0820.

15.

A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.

Zeglis BM, Sevak KK, Reiner T, Mohindra P, Carlin SD, Zanzonico P, Weissleder R, Lewis JS.

J Nucl Med. 2013 Aug;54(8):1389-96. doi: 10.2967/jnumed.112.115840. Epub 2013 May 24.

16.

(64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.

Kumar SR, Gallazzi FA, Quinn TP, Deutscher SL.

J Nucl Med. 2011 Nov;52(11):1819-26. doi: 10.2967/jnumed.111.093716. Epub 2011 Oct 7.

17.

Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation.

Kang CS, Wu N, Chen Y, Sun X, Bandara N, Liu D, Lewis MR, Rogers BE, Chong HS.

J Inorg Biochem. 2016 Jan;154:60-6. doi: 10.1016/j.jinorgbio.2015.10.012. Epub 2015 Oct 30.

18.

Site-Specifically Labeled Antibody-Drug Conjugate for Simultaneous Therapy and ImmunoPET.

Adumeau P, Vivier D, Sharma SK, Wang J, Zhang T, Chen A, Agnew BJ, Zeglis BM.

Mol Pharm. 2018 Mar 5;15(3):892-898. doi: 10.1021/acs.molpharmaceut.7b00802. Epub 2018 Feb 2.

19.

Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.

Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.

J Nucl Med. 2004 Oct;45(10):1776-83.

20.

Click-chemistry strategy for labeling antibodies with copper-64 via a cross-bridged tetraazamacrocyclic chelator scaffold.

Kumar A, Hao G, Liu L, Ramezani S, Hsieh JT, Öz OK, Sun X.

Bioconjug Chem. 2015 Apr 15;26(4):782-9. doi: 10.1021/acs.bioconjchem.5b00102. Epub 2015 Mar 19.

PMID:
25760776

Supplemental Content

Support Center